CX Institutional lowered its position in shares of McDonald’s Co. (NYSE:MCD – Get Rating) by 31.5% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,276 shares of the fast-food giant’s stock after selling 2,889 shares during the quarter. CX Institutional’s holdings in McDonald’s were worth $1,448,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently modified their holdings of the company. Gladstone Institutional Advisory LLC lifted its position in shares of McDonald’s by 57.8% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 24,941 shares of the fast-food giant’s stock worth $5,755,000 after buying an additional 9,132 shares in the last quarter. Garrett Investment Advisors LLC lifted its position in shares of McDonald’s by 8.2% during the 2nd quarter. Garrett Investment Advisors LLC now owns 3,660 shares of the fast-food giant’s stock worth $904,000 after buying an additional 276 shares in the last quarter. Bartlett & Co. LLC lifted its position in shares of McDonald’s by 0.3% during the 3rd quarter. Bartlett & Co. LLC now owns 172,083 shares of the fast-food giant’s stock worth $39,709,000 after buying an additional 486 shares in the last quarter. Wealthspire Advisors LLC lifted its position in shares of McDonald’s by 6.2% during the 2nd quarter. Wealthspire Advisors LLC now owns 11,355 shares of the fast-food giant’s stock worth $2,803,000 after buying an additional 661 shares in the last quarter. Finally, Nikulski Financial Inc. raised its holdings in shares of McDonald’s by 1.9% in the 2nd quarter. Nikulski Financial Inc. now owns 7,717 shares of the fast-food giant’s stock worth $1,905,000 after purchasing an additional 143 shares during the period. Institutional investors own 66.86% of the company’s stock.
McDonald’s Stock Up 0.1 %
McDonald’s stock opened at $269.56 on Wednesday. The firm has a fifty day simple moving average of $269.69 and a two-hundred day simple moving average of $260.95. McDonald’s Co. has a twelve month low of $217.68 and a twelve month high of $302.00. The company has a market capitalization of $197.43 billion, a PE ratio of 33.95, a P/E/G ratio of 3.14 and a beta of 0.63.
Analyst Upgrades and Downgrades
MCD has been the topic of a number of research reports. KeyCorp lifted their price target on shares of McDonald’s from $290.00 to $295.00 and gave the stock an “overweight” rating in a report on Friday, October 28th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of McDonald’s from $262.00 to $263.00 in a report on Thursday, January 5th. Wedbush lifted their price objective on shares of McDonald’s from $265.00 to $300.00 and gave the company an “outperform” rating in a research note on Thursday, October 27th. Cowen lifted their price objective on shares of McDonald’s from $280.00 to $293.00 and gave the company an “outperform” rating in a research note on Friday, October 28th. Finally, Wells Fargo & Company initiated coverage on shares of McDonald’s in a research note on Monday. They issued an “equal weight” rating and a $280.00 price objective for the company. Five analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. Based on data from MarketBeat, McDonald’s presently has an average rating of “Moderate Buy” and an average price target of $288.96.
McDonald’s Company Profile
McDonald’s Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K.
Further Reading
- Get a free copy of the StockNews.com research report on McDonald’s (MCD)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Want to see what other hedge funds are holding MCD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McDonald’s Co. (NYSE:MCD – Get Rating).
Receive News & Ratings for McDonald's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McDonald's and related companies with MarketBeat.com's FREE daily email newsletter.